Medline Inc. L10
| 09/26/2026 | 06/27/2026 | 12/31/2025 | 12/31/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.41% | 11.60% | 14.78% | 14.78% | 11.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.41% | 11.60% | 14.78% | 14.78% | 11.33% |
| Cost of Revenue | 14.52% | 16.48% | 19.06% | 19.06% | 10.13% |
| Gross Profit | -1.07% | -1.15% | 3.40% | 3.40% | 14.62% |
| SG&A Expenses | 12.81% | 19.24% | 8.68% | 8.68% | 11.27% |
| Depreciation & Amortization | -0.56% | 0.57% | -0.56% | -0.56% | 4.76% |
| Other Operating Expenses | 25.00% | -14.29% | 87.50% | 87.50% | 600.00% |
| Total Operating Expenses | 13.84% | 16.45% | 16.76% | 16.76% | 10.37% |
| Operating Income | -28.57% | -36.57% | -10.32% | -10.32% | 21.90% |
| Income Before Tax | 11.88% | -34.54% | -32.46% | -32.46% | 19.67% |
| Income Tax Expenses | 195.65% | 269.23% | 62.50% | 62.50% | 225.00% |
| Earnings from Continuing Operations | -1.24% | -58.26% | -37.72% | -37.72% | 14.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.44% | -81.98% | -37.02% | -37.02% | 14.04% |
| EBIT | -28.57% | -36.57% | -10.32% | -10.32% | 21.90% |
| EBITDA | -19.11% | -25.48% | -5.76% | -5.76% | 16.58% |
| EPS Basic | 1,127.72% | 237.89% | 1,261.82% | 1,261.82% | -- |
| Normalized Basic EPS | 474.80% | 562.10% | 1,858.18% | 1,858.18% | -- |
| EPS Diluted | 1,089.13% | 237.89% | 1,261.82% | 1,261.82% | -- |
| Normalized Diluted EPS | 282.93% | 558.87% | 1,858.18% | 1,858.18% | -- |
| Average Basic Shares Outstanding | -94.99% | -95.10% | -95.36% | -95.36% | -- |
| Average Diluted Shares Outstanding | -92.47% | -95.08% | -95.36% | -95.36% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.89% | -0.89% | 3.54% |